Close
Nordic 9Nordic 9

AurorA Science (investor - Others)

Italy aurorascience.eu
See something wrong or missing? Let us know
Offices:Milan

AurorA Science (Aurora-TT Srl) is a Milan-based commercial technology transfer company.

Average round investment:9.85M USD
Average number per year:1.0
Distribution: 2026 (1)2020 (1)
Portfolio companies: Spain Peptomyc
Mostly invests in: Spain Spain (2) Biotech (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to AurorA Science

Name Criteria
France Advent France Biotechnology
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States North South Ventures
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Switzerland AVANTECA Partners
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Spain GAEA Inversion
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States Fifty Years
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United States Ataraxia
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Spain Nara Capital
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
Spain Cleon Capital
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United Kingdom Blue Wire Capital
81%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 4.1
  • Active last 12 months: Yes
Germany Shio Capital
81%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 4.4
  • Active last 12 months: Yes
Top